Status:
RECRUITING
Organoid-guided Personalized Treatment of Pleural Effusion
Lead Sponsor:
Henan Cancer Hospital
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The study is a single-arm, single-center clinical research that utilizes patient-derived tumor organoids to predict drug sensitivity, thereby assisting clinicians in formulating treatment plans to ben...
Detailed Description
Research name：Organoid-guided personalized treatment of pleural effusion. Intervention study: Not have. Research design: The study is a single-arm, single-center clinical research that utilizes pati...
Eligibility Criteria
Inclusion
- (1)18 years of age and above; (2) Understand and voluntarily sign the informed consent form (ICF), and have good compliance, and can cooperate with diagnosis and follow-up; (3)ECOG score 0-2; (4) Accompanied by malignant pleural effusion; Presence of at least one measurable lesion as assessed by the investigator;
Exclusion
- A history of malignant tumor in the past 5 years;
- Complicated with serious complications, such as uncontrolled heart disease, severe arrhythmia requiring medical treatment, persistent watery diarrhea, etc.;
- Pregnant or lactating female patients; Patients deemed unsuitable for participation in this study.
Key Trial Info
Start Date :
February 21 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06959173
Start Date
February 21 2025
End Date
January 1 2027
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Henan cancer hospital
Zhengzhou, Henan, China, 475000